PRECLINICAL CHARACTERISATION OF MIV-802, A NOVEL URIDINE NUCLEOTIDE HCV NS5B POLYMERASE INHIBITOR, FOR TREATMENT OF HEPATITIS C VIRUS INFECTIONJOURNAL OF HEPATOLOGYIF332015-04-013PREAI
Synthesis of P1′-Functionalized Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary AlcoholJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-08-0114PREAI
Pharmacological characterization of the potent, selective and orally active cathepsin K inhibitor MIV-711BONEIF3.62012-05-011PREAI
Effect of the selective cathepsin K inhibitor MIV-711 on bone resorption and cartilage degradation biomarkers and on knee joint pathology in dogs subjected to partial medial meniscectomy, an experimental model of osteoarthritisBONEIF3.62012-05-011PREAI
Synthesis, X-ray Analysis, and Biological Evaluation of a New Class of Stereopure Lactam-Based HIV-1 Protease InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82012-03-1329OAAI
Aliskiren displays long-lasting interactions with human reninNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGYIF3.12011-12-236PREAI
EFFECT OF THE SELECTIVE CATHEPSIN K INHIBITOR, MIV-711, ON MARKERS OF CARTILAGE DEGRADATION AND ON GROSS AND HISTOPATHOLOGY SCORES IN DOGS SUBJECTED TO PARTIAL MEDIAL MENISCECTOMY, AN EXPERIMENTAL MODEL OF OSTEOARTHRITISOSTEOARTHRITIS AND CARTILAGEIF92011-09-010OAAI
Inhibition of HIV-1 by non-nucleoside reverse transcriptase inhibitors via an induced fit mechanism-Importance of slow dissociation and relaxation rates for antiviral efficacyBIOCHEMICAL PHARMACOLOGYIF5.62010-10-0120OAAI
In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435ANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52010-05-01210OAAI
Induced-Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease TargetANGEWANDTE CHEMIE-INTERNATIONAL EDITIONIF16.92010-02-1793PREAI
Design and Synthesis of Potent and Selective BACE-1 InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82010-02-0330PRE
Discovery of potent BACE-1 inhibitors containing a new hydroxyethylene (HE) Scaffold: Exploration of P1′ alkoxy residues and an aminoethylene (AE) central coreBIOORGANIC & MEDICINAL CHEMISTRYIF32010-02-0115PRE
Design and synthesis of novel P2 substituents in diol-based HIV protease inhibitorsEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92010-01-0114PREAI
In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease InhibitorANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52009-04-01182OAAI
Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitorsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52008-08-0117OAAI
Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease:: Use of cyclopentane and cyclopentene P2-motifsBIOORGANIC & MEDICINAL CHEMISTRYIF32007-11-0140PRE
A new structural theme in C2-symmetric HIV-1 protease inhibitors:: ortho-Substituted P1/P1′ side chainsBIOORGANIC & MEDICINAL CHEMISTRYIF32006-08-0131PRE
Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and IIBIOORGANIC & MEDICINAL CHEMISTRYIF32005-09-0141PRE
Design and synthesis of potent inhibitors of plasmepsin I and II:: X-ray crystal structure of inhibitor in complex with plasmepsin IIJOURNAL OF MEDICINAL CHEMISTRYIF6.82005-06-0233PREAI